Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BIM) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Kopetz, S.; Grothey, A.; Yaeger, R.; Cuyle, P. J. A. R.; Huijberts, S.; Schellens, J. H. M.; Elez, E.; Fakih, M.; Viladot, C. M.; Peeters, M.; Desai, J.; Yoshino, T.; Ciardiello, F.; Wasan, H. S.; Maharry, K.; Christy-Bittel, J.; Gollerkeri, A.; Van Cutsem, E.; Tabernero, J. |
| Abstract Title: | Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BIM) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC) |
| Meeting Title: | 2019 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Jan 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-02-01 |
| Language: | English |
| ACCESSION: | WOS:000489107600690 |
| DOI: | 10.1200/JCO.2019.37.4_suppl.688 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 688 -- Source: Wos |
